GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (FRA:2Q5) » Definitions » Float Percentage Of Total Shares Outstanding

Renovaro (FRA:2Q5) Float Percentage Of Total Shares Outstanding : 64.62% (As of Jun. 04, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Renovaro Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Renovaro's float shares is 95.31 Mil. Renovaro's total shares outstanding is 147.50 Mil. Renovaro's float percentage of total shares outstanding is 64.62%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Renovaro's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Renovaro's Institutional Ownership is 5.43%.

Renovaro Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Renovaro's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=95.31/147.50
=64.62%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renovaro (FRA:2Q5) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (FRA:2Q5) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
AEON SCPH INZY ENTA MCRB IVVD GRTS DNTH CBUS PSTX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
RENB:USA 2Q5:Germany
Address
2080 Century Park East, Suite 906, Los Angeles, CA, USA, 90067
Website
https://www.enochianbio.com
Renovaro Biosciences Inc Formerly Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.

Renovaro (FRA:2Q5) Headlines

No Headlines